German
|
English
|
French
Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "L01FY" (3)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Pertuzumab and Trastuzumab (L01FY01) 2 products
WHO-DDD
L
IP
Phesgo 600 mg/600 mg/10 ml
3313.89
3620.45
10 %
Injection solution: 2 Active Agents
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
IP
Phesgo 1200 mg/600 mg/15 ml
5759.61
6217.15
10 %
Injection solution: 2 Active Agents
Roche Pharma
(Schweiz) AG
A / SL
FB
G
Nivolumab and Relatlimab (L01FY02) 1 products
WHO-DDD
L
IP
Opdualag (80 mg
Relatlimab / 240 mg
Nivolumab pro 20 ml)
5509.10
5960.15
10 %
Concentrate for infusion: 2 Active Agents
Bristol-Myers Squibb SA
A / SL
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
